-+ 0.00%
-+ 0.00%
-+ 0.00%

FDA accepts Cogent Biosciences’ bezuclastinib NDA for NonAdvSM, sets PDUFA date of Dec. 30, 2026

Reuters·03/16/2026 12:03:25

Please log in to view news